8-K - Praxis Precision Medicines, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Praxis Precision Medicines, Inc. furnished its press release dated February 19, 2026, under Item 2.02 as Exhibit 99.1, relating to results of operations. The filing includes references to analyst consensus EPS context for the period.

Key Takeaways

1Item 2.02 Results of Operations furnished, including Exhibit 99.1 Press Release dated 2026-02-19

2Item 9.01 Financial Statements and Exhibits with Exhibit 99.1 and 104

3Consensus EPS for 2026-02-19: $-3.50 vs estimate $-3.13 (-12.0%)

4Prior consensus: 2025-11-05 EPS $-3.36 vs est $-3.45 (+2.6%)

5Forward consensus 2027-03-31 EPS $-3.97

6Forward consensus 2027-06-30 EPS $-3.68

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act

Financial Results

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated February 19 , 2026 104 Cover Page Interactive Data File (emb

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1